|
|
Preface Myalgic Encephalopathy (ME) is the preferred term of the Alison Hunter Memorial Foundation People with ME face enormous obstacles to access equitable health care. Among the impediments over the past decade has been research which shifted emphasis to fatigue, fatigue states and chronic fatigue with scant regard for the myriad yet distinguishing neurological, autonomic, and gastrointestinal features of ME. Both the inadequacy of fatigue as a descriptor for the incapacitating post exertional malaise of ME, and the prevalence of fatigue as a common experience and complaint (eg driver fatigue, hiking fatigue, most disease states) compound the difficulties. Semantics and biased attributions continue to deny the very ill, both child and adult, the right to care which addresses their acute and chronic medical needs, without fear. The Countess of Mar in the House of Lords, United Kingdom (1) has recorded the disproportionate suffering of the young with ME, when serious physical symptoms are dismissed with wide ranging psychiatric diagnoses. As a consequence families become embroiled in medical disputes over punitive treatment regimes. Child protection orders can ensue when the judiciary are limited in their ability to evaluate expert testimonies (2). In some cases young people have been removed from their families to foster care for periods of up to five years. The recent editorial by Martin Van Der Weyden in the Medical Journal of Australia (MJA) (3) explored the important characteristics of the "distinguished clinician". One of the foremost is "an absence of arrogance (the transmitted aura of infallibility or overbearing manner or attitude)" epitomised by Dr Francis Peabody (1927) who wrote:
These qualities shine in the seminal works of the "distinguished clinicians" Melvin Ramsey (4), John Richardson (5), and Andrew Wallis (6) with their meticulous and compassionate documentation of "the clinical identity of the myalgic encephalomyelitis syndrome". Gross deficiencies in the scientific evidence have been asserted in the joint statement on behalf of the Royal Australasian College of Physicians and the ME Chronic Fatigue Syndrome Association of Australia published in the MJA (7)
It will take priority funding initiatives and time for scientific advances to impact on therapies specific to the many potential disease states of differing aetiologies encompassed under the umbrella of ME. The consequent delays to treatment for people with ME reinforce the vital role of the "distinguished clinician". The 2001 Proceedings herald exciting international scientific advances, and will assist the medical practitioner to improve differential diagnosis and clinical care. Importantly, the Proceedings affirm hope for people with ME.
Christine
Hunter, Annette Leggo Ellie
Stein MD FRCP (C)
References
Latest News | Research | Information | Advocacy | Conference | Guidelines
|